NCT04357717 - ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST

ExoDx Prostate

Urine-based biomarker tool to support decision to biopsy in patients with PSA between 2-10ng/ml

Trial Locations (2)

Chesapeake Urology Research Associates, Baltimore

New Jersey Urology, Voorhees Township